Novo Nordisk to advance subcutaneous and oral amycretin for weight management into phase 3 clinical development
The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities
The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities
The 27 greenfield labs across the country ensure timely and accurate reporting
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Collaboration combines data, identity capture and Web 3.0 crypto technologies to enhance product safety, traceability, and data integrity for AI systems
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
Plans underway to expand screening capacity by 50% for greater accessibility
The conference featured comprehensive discussions, field visits, and knowledge-sharing sessions addressing different aspect of major NCDs
Increases speed to market for drug developers working on nucleic acid therapeutics
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Subscribe To Our Newsletter & Stay Updated